Boston Scientific Corporation  

(Public, NYSE:BSX)   Watch this stock  
Find more results for bsx
16.62
-0.72 (-4.15%)
Feb 5 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 16.58 - 17.43
52 week 14.18 - 19.06
Open 17.25
Vol / Avg. 0.00/10.78M
Mkt cap 21.43B
P/E     -
Div/yield     -
EPS -0.18
Shares 1.35B
Beta 0.98
Inst. own 94%
May 4, 2016
Boston Scientific Corp Annual Shareholders Meeting (Estimated) - 11:00AM EDT - Add to calendar
Apr 26, 2016
Q1 2016 Boston Scientific Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Feb 10, 2016
Boston Scientific Corp at Leerink Partners Global Healthcare Conference - 1:50PM EST - Add to calendar
Feb 4, 2016
Q4 2015 Boston Scientific Corp Earnings Release
Feb 4, 2016
Q4 2015 Boston Scientific Corp Earnings Call - Webcast
Jan 12, 2016
Boston Scientific Corp at JPMorgan Healthcare Conference Q&A session
Jan 12, 2016
Boston Scientific Corp at JPMorgan Healthcare Conference
Dec 8, 2015
Boston Scientific Corp at Oppenheimer Healthcare Conference - Webcast
Dec 1, 2015
Boston Scientific Corp at Piper Jaffray Healthcare Conference - Webcast
Nov 19, 2015
Boston Scientific Corp at Canaccord Genuity Medical Technology & Diagnostics Forum
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -7.18% -3.20%
Operating margin -13.70% -4.37%
EBITD margin - 20.62%
Return on average assets -3.13% -1.36%
Return on average equity -8.95% -3.74%
Employees 24,000 -
CDP Score - 46

Address

300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
United States - Map
+1-508-6834000 (Phone)
+1-508-6508923 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Women’s Health, and Neuromodulation.

Officers and directors

Peter M. Nicholas Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael F. Mahoney President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Joseph M. Fitzgerald Executive Vice President and President - Rhythm Management
Age: 51
Bio & Compensation  - Reuters
Daniel Brennan Chief Financial Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
Timothy A. Pratt Chief Administrative Officer, Executive Vice President, General Counsel, Secretary
Age: 65
Bio & Compensation  - Reuters
Supratim Bose Executive Vice President and President - Asia-Pacific, Middle East and Africa
Age: 62
Bio & Compensation  - Reuters
Keith D. Dawkins M.D. Global Chief Medical Officer, Executive Vice President
Age: 64
Bio & Compensation  - Reuters
Michael P. Phalen Executive Vice President and President - MedSurg
Age: 55
Bio & Compensation  - Reuters
Wendy Carruthers Senior Vice President - Human Resources
Age: 46
Bio & Compensation  - Reuters
Kevin J. Ballinger Senior Vice President and President, Interventional Cardiology
Age: 42
Bio & Compensation  - Reuters